JAMA Cardiology

Papers
(The H4-Index of JAMA Cardiology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Knowing More Than the Knowns in Familial Hypercholesterolemia434
Error in Table 1264
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?259
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply253
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling221
Primary Prevention Management of Elevated Lipoprotein(a)219
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP205
A Woman With Recurrent Torsade de Pointes192
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious174
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease171
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy170
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction165
Chest Pain in a Middle-Aged Man164
Genome-Wide Association Study of Accessory Atrioventricular Pathways155
USPSTF Report on Aspirin for Primary Prevention154
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership152
JAMA Cardiology144
JAMA Cardiology142
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals142
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden132
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic131
Accountable Care Organization Participation and Cardiovascular Care Quality128
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure124
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF120
Midlife Wealth Mobility and Long-term Cardiovascular Health118
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors115
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction114
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes112
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction111
JAMA Cardiology109
What Is Your Secret to Health?107
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply102
Supraventricular Tachycardia Following Mitral Valve Surgery99
Assessing Performance of Machine Learning—Reply98
JAMA Cardiology—The Year in Review, 202095
JAMA Cardiology95
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation94
Hypertriglyceridemia in the MESA Study—Reply91
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US87
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?87
Contribution of Clinical Trial Event Data by Data Source86
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features84
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone81
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease81
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction79
Transthyretin Cardiac Amyloidosis in the Elderly—Tip of a Heart Failure Iceberg?77
Interpreting Health Status Measures in Patients With Heart Failure—What Counts76
Innovation in Event Adjudication—Human vs Machine76
Peak Oxygen Uptake vs Ventilatory Efficiency73
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker69
Identification of Cardiac Fibrosis in Young Adults With a Homozygous Frameshift Variant in SERPINE169
Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels69
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction69
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm68
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?68
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer68
Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?—New Measures to Quantify Subclinical Systolic Dysfunction68
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts68
Corrected to Open Access Status67
Change to Open Access Status67
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States66
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency66
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL166
Genetic Studies of Atrial Fibrillation in Diverse Cohorts and Identification of Diverse Phenotypes Associated With Single Genes66
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US64
0.12243914604187